These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 34091050)

  • 21. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
    Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant Incidental Findings in the National Lung Screening Trial.
    Gareen IF; Gutman R; Sicks J; Tailor TD; Hoffman RM; Trivedi AN; Flores E; Underwood E; Cochancela J; Chiles C
    JAMA Intern Med; 2023 Jul; 183(7):677-684. PubMed ID: 37155190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Low-dose Chest CT Screening on the Association Between Rurality and Lung Cancer Outcomes.
    Hinojos M; Li X; Mikesell S; Studden S; Odean M; Boylan MJ; Arvold DS; Bachelder VD; Gowda N; Arvold ND
    Am J Clin Oncol; 2022 Dec; 45(12):519-525. PubMed ID: 36326127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
    Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
    Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.
    Kerpel-Fronius A; Megyesfalvi Z; Markóczy Z; Solymosi D; Csányi P; Tisza J; Kecskés A; Baranyi B; Csánky E; Dóka A; Gálffy G; Göcző K; Győry C; Horváth Z; Juhász T; Kállai Á; Kincses ZT; Király Z; Király-Incze E; Kostyál L; Kovács A; Kovács A; Kuczkó É; Makra Z; Maurovich Horvát P; Merth G; Moldoványi I; Müller V; Pápai-Székely Z; Papp D; Polgár C; Rózsa P; Sárosi V; Szalai Z; Székely A; Szuhács M; Tárnoki D; Tavaszi G; Turóczi-Kirizs R; Tóth L; Urbán L; Vaskó A; Vigh É; Dome B; Bogos K
    Eur Radiol; 2024 May; 34(5):3462-3470. PubMed ID: 37921926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases.
    Pinsky PF; Lynch DA; Gierada DS
    Chest; 2022 Apr; 161(4):1092-1100. PubMed ID: 34838524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
    Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
    Goulart BH; Ramsey SD
    Oncologist; 2013; 18(8):941-6. PubMed ID: 23873718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
    Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
    Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose computed tomography screening for lung cancer: results of the first screening round.
    Horeweg N; Nackaerts K; Oudkerk M; de Koning HJ
    J Comp Eff Res; 2013 Sep; 2(5):433-6. PubMed ID: 24236740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.
    Pinsky PF; Gierada DS; Hocking W; Patz EF; Kramer BS
    Ann Intern Med; 2014 Nov; 161(9):627-33. PubMed ID: 25199624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.
    Baldwin DR; Callister ME
    Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis: is low-dose computed tomography a superior method for risky lung cancers screening population?
    Fu C; Liu Z; Zhu F; Li S; Jiang L
    Clin Respir J; 2016 May; 10(3):333-41. PubMed ID: 25307063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [China National Lung Cancer Screening Guideline with Low-dose Computed 
Tomography (2018 version)].
    Zhou Q; Fan Y; Wang Y; Qiao Y; Wang G; Huang Y; Wang X; Wu N; Zhang G; Zheng X; Bu H; Li Y; Wei S; Chen L; Hu C; Shi Y; Sun Y
    Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):67-75. PubMed ID: 29526173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer screening using low-dose CT: the current national landscape.
    Eberth JM; Qiu R; Adams SA; Salloum RG; Bell N; Arrington AK; Linder SK; Munden RF
    Lung Cancer; 2014 Sep; 85(3):379-84. PubMed ID: 25088660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
    Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
    Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network.
    Petousis P; Han SX; Aberle D; Bui AA
    Artif Intell Med; 2016 Sep; 72():42-55. PubMed ID: 27664507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.